newsfilter
← Latest News
Business Wire·

NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms

Approximately 16 million Americans suffer from dry eye disease with the U.S. market for dry eye treatment projected to reach $4.86 billion by 2030 NovaBay® Pharmaceuticals, Inc. (NYSE:NBY), a company developing